OLPX News and Press, Olaplex Holdings Inc. From 02/14/23

SANTA BARBARA, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (“OLAPLEX”), today announced that it plans to report fourth quarter and fiscal 2022 financial results before the market opens on Tuesday, February 28, 2023. The company plans to host an investor co...

Summary My January 2023 income is multiples higher than my January 2022 dividend income. I made two sales in my portfolio and added one new position. Six of my portfolio companies increased their dividends and I'm anticipating several February dividend raises. I’m e...

Summary Edgewell Personal Care Company has faced a bit of pressure as of late on both its top and bottom lines. This may discourage some investors from considering the firm, but management seems upbeat for 2023, all things considered. Shares are also priced at a level that suggests ...

Summary My portfolio generated dividend growth of 11.4% in 2022. I added four new positions in December 2022 and added to several existing positions. My portfolio saw 6 dividend raises and no dividend cuts in December 2022. I am anticipating 4 dividend raises in January 2023. ...

Summary I look at my updated top 10 holdings and note which companies I want to add to and which ones I intend to leave steady. I highlight some "Compounder" names I'm looking to add in 2023. I touch on the four new positions I added to my portfolio this month. I discuss four co...

Summary Estée Lauder ranks amongst the industry leaders in terms of valuation, edging L’Oréal on P/E and EV/EBITDA ratios. The company’s revenue contracted 16% YoY and the outlook is grim, with EPS targets down 57% YoY and a 10% revenue decline for the last twelv...

New York, New York--(Newsfile Corp. - December 20, 2022) - Levi & Korsinsky, LLP notifies investors in Olaplex Holdings, Inc. ("Olaplex" or the "Company") (NASDAQ: OLPX) of a class action securities lawsuit. The lawsuit on behalf of Olaplex investors has been commenced in the the United St...

Summary P&G is stronger in a number of areas compared to Unilever, including having a higher operating margin and stronger revenue growth. Both companies are currently facing similar challenges, such as competition from fierce startups and from supermarket private labels. Unilev...

Summary Olaplex can afford to significantly increase its marketing costs because the company has abnormally high margins. The company's portfolio includes only 14 products, and management plans to release several new products annually. It seems that the market has already reflected ...

Summary Olaplex is expected to increase sales 18% in 2022, and has consistently reported 35%+ net income margins while growing at a CAGR of 70% between 2019-2021. Management mistakes in Q2-2022 created uncertainties about the company's ability to continue growing, but giant untapped gro...